www.humira.com Open in urlscan Pro
2600:9000:223e:fc00:5:8ced:94c0:93a1  Public Scan

Submitted URL: http://hcenroll.com/
Effective URL: https://www.humira.com/humira-complete/register/
Submission: On December 10 via api from TR — Scanned from DE

Form analysis 1 forms found in the DOM

POST

<form id="fileUploadForm" enctype="multipart/form-data" method="post" target="fileUploadIframe"><input type="file" id="fileSelector" name="file" style="display: none;"><input name="filename" type="hidden"></form>

Text Content

Health insurance coverage changing? Call 1.800.4HUMIRA or click to see how we
can help ▸

Skip to Main content
 * Choose Condition
    * Moderate to Severe Rheumatoid Arthritis
    * Moderate to Severe Chronic Plaque Psoriasis
    * Moderate to Severe Crohn's Disease
    * Moderate to Severe Pediatric Crohn's Disease
    * Moderate to Severe Ulcerative Colitis
    * Moderate to Severe Pediatric Ulcerative Colitis
    * Psoriatic Arthritis
    * Moderate to Severe Hidradenitis Suppurativa
    * Ankylosing Spondylitis
    * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
    * Non-Infectious Intermediate, Posterior, and Panuveitis

 * Important Safety Information
 * Full Prescribing Information & Patient Information
    * Full Prescribing Information (English)
    * Full Prescribing Information (En Español)
    * Medication Guide

 * Health Care Professionals

 * HUMIRA Complete Answers

Cost & Savings
 * Cost & Savings
 * Log In or Sign Up

 * 
 * logout
 * Humira Complete



 * HOME
 * LEARN ABOUT HUMIRA
    * Moderate to Severe Rheumatoid Arthritis
    * Moderate to Severe Chronic Plaque Psoriasis
    * Moderate to Severe Crohn's Disease
    * Moderate to Severe Pediatric Crohn's Disease
    * Moderate to Severe Ulcerative Colitis
    * Moderate to Severe Pediatric Ulcerative Colitis
    * Psoriatic Arthritis
    * Moderate to Severe Hidradenitis Suppurativa
    * Ankylosing Spondylitis
    * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
    * Non-Infectious Intermediate, Posterior, and Panuveitis
    * Additional Safety Information

 * STARTING HUMIRA
    * About HUMIRA Complete
    * Resources for You
    * Save on HUMIRA
    * Check Your Insurance Coverage
    * Insurance Explained
    * Understanding insurance coverage changes
    * Your HUMIRA Ambassador
    * How to Inject HUMIRA
    * Sign Up for HUMIRA Complete

 * HUMIRA COMPLETE RESOURCES
    * Complete Resource Center
    * Log In or Sign Up
    * Logout
    * HUMIRA and Your Routine
    * HUMIRA Complete Answers

 * Hello {{firstName}}
    * Cost & Savings
    * Log In or Sign Up


SIGN UP FOR HUMIRA COMPLETE


RESOURCES FOR YOUR TREATMENT JOURNEY.

With HUMIRA Complete, you have access to helpful resources, ways you could save
on your prescription, and one-to-one support from a dedicated HUMIRA Complete
Nurse Ambassador.*


YOU MAY BE ABLE TO PAY $5 A MONTH FOR YOUR HUMIRA PRESCRIPTION.†

Let’s see if you’re eligible for the HUMIRA Complete Savings Card. The type of
health insurance you have will determine your eligibility.

See Terms and Conditions


ORDER YOUR HUMIRA COMPLETE RESOURCES.

Receive a step-by-step guide on how to inject, a travel case to hold your
medication, and a Sharps Container and Mail-back Disposal Kit for a safe and
convenient way to dispose of your HUMIRA Pens or syringes.

 

 


YOUR HUMIRA COMPLETE NURSE AMBASSADOR*

As part of HUMIRA Complete, you have a dedicated Nurse Ambassador with you right
from the start who will:

 * Find ways to help you save on HUMIRA
 * Provide supplemental injection training
 * Encourage you to establish a routine

See how your Nurse Ambassador can support you on your treatment journey.

Watch Video Now


CREATE YOUR PROFILE.

By creating a profile for your online HUMIRA Complete account, you’ll be able to
access all your HUMIRA Complete resources, including:

 * Information about how to save on HUMIRA
 * Supplemental injection training
 * Medication reminders and more


REVIEW AND CONFIRM YOUR INFORMATION.

Take a moment to review the information you’ve provided and make any necessary
updates.


FINALIZE YOUR ACCOUNT DETAILS.

You’ll need a password to access your account to update your profile, order
resources, and set medication reminders.



--------------------------------------------------------------------------------

If you have questions about HUMIRA Complete or need further assistance, give us
a call at 1.800.4HUMIRA (1.800.448.6472)

*Nurse Ambassadors are provided by AbbVie and do not work under the direction of
your health care professional (HCP) or give medical advice. They are trained to
direct patients to their HCP for treatment-related advice, including further
referrals.



*Eligibility: Available to patients with commercial insurance coverage for
HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance
program is not available to patients receiving prescription reimbursement under
any federal, state, or government-funded insurance programs (for example,
Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE,
Department of Defense, or Veterans Affairs programs) or where prohibited by law.
Offer subject to change or termination without notice. Restrictions, including
monthly maximums, may apply. This is not health insurance. For full Terms and
Conditions, visit HUMIRASavingsCard.com or call 1.800.4HUMIRA for additional
information. To learn about AbbVie’s privacy practices and your privacy choices,
visit https://privacy.abbvie



View full terms and conditions


IMPORTANT SAFETY INFORMATION 
ABOUT HUMIRA® (ADALIMUMAB)1


WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA?

You should discuss the potential benefits and risks of HUMIRA with your doctor.
HUMIRA is a TNF blocker medicine that can lower the ability of your immune
system to fight infections. You should not start taking HUMIRA if you have any
kind of infection unless your doctor says it is okay.

 * Serious infections have happened in people taking HUMIRA. These serious
   infections include tuberculosis (TB) and infections caused by viruses, fungi,
   or bacteria that have spread throughout the body. Some people have died from
   these infections. Your doctor should test you for TB before starting HUMIRA,
   and check you closely for signs and symptoms of TB during treatment with
   HUMIRA, even if your TB test was negative. If your doctor feels you are at
   risk, you may be treated with medicine for TB.
 * Cancer. For children and adults taking TNF blockers, including HUMIRA, the
   chance of getting lymphoma or other cancers may increase. There have been
   cases of unusual cancers in children, teenagers, and young adults using TNF
   blockers. Some people have developed a rare type of cancer called
   hepatosplenic T-cell lymphoma. This type of cancer often results in death. If
   using TNF blockers including HUMIRA, your chance of getting two types of skin
   cancer (basal cell and squamous cell) may increase. These types are generally
   not life-threatening if treated; tell your doctor if you have a bump or open
   sore that doesn’t heal.


WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA?

Tell your doctor about all of your health conditions, including if you:

 * Have an infection, are being treated for infection, or have symptoms of an
   infection
 * Get a lot of infections or infections that keep coming back
 * Have diabetes
 * Have TB or have been in close contact with someone with TB, or were born in,
   lived in, or traveled where there is more risk for getting TB
 * Live or have lived in an area (such as the Ohio and Mississippi River
   valleys) where there is an increased risk for getting certain kinds of fungal
   infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis.
   These infections may happen or become more severe if you use HUMIRA. Ask your
   doctor if you are unsure if you have lived in these areas
 * Have or have had hepatitis B
 * Are scheduled for major surgery
 * Have or have had cancer
 * Have numbness or tingling or a nervous system disease such as multiple
   sclerosis or Guillain-Barré syndrome
 * Have or had heart failure
 * Have recently received or are scheduled to receive a vaccine. HUMIRA patients
   may receive vaccines, except for live vaccines. Children should be brought up
   to date on all vaccines before starting HUMIRA
 * Are allergic to rubber, latex, or any HUMIRA ingredients
 * Are pregnant, planning to become pregnant, breastfeeding, or planning to
   breastfeed
 * Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s
   doctor before your baby receives any vaccines

Also tell your doctor about all the medicines you take. You should not take
HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab),
ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab).
Tell your doctor if you have ever used RITUXAN® (rituximab),
IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).


WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA?

HUMIRA can cause serious side effects, including:

 * Serious infections. These include TB and infections caused by viruses, fungi,
   or bacteria. Symptoms related to TB include a cough, low-grade fever, weight
   loss, or loss of body fat and muscle.
 * Hepatitis B infection in carriers of the virus. Symptoms include muscle
   aches, feeling very tired, dark urine, skin or eyes that look yellow, little
   or no appetite, vomiting, clay-colored bowel movements, fever, chills,
   stomach discomfort, and skin rash.
 * Allergic reactions. Symptoms of a serious allergic reaction include hives,
   trouble breathing, and swelling of your face, eyes, lips, or mouth.
 * Nervous system problems. Signs and symptoms include numbness or tingling,
   problems with your vision, weakness in your arms or legs, and dizziness.
 * Blood problems (decreased blood cells that help fight infections or stop
   bleeding). Symptoms include a fever that does not go away, bruising or
   bleeding very easily, or looking very pale.
 * Heart failure (new or worsening). Symptoms include shortness of breath,
   swelling of your ankles or feet, and sudden weight gain.
 * Immune reactions including a lupus-like syndrome. Symptoms include chest
   discomfort or pain that does not go away, shortness of breath, joint pain, or
   rash on your cheeks or arms that gets worse in the sun.
 * Liver problems. Symptoms include feeling very tired, skin or eyes that look
   yellow, poor appetite or vomiting, and pain on the right side of your stomach
   (abdomen). These problems can lead to liver failure and death.
 * Psoriasis (new or worsening). Symptoms include red scaly patches or raised
   bumps that are filled with pus.

Call your doctor or get medical care right away if you develop any of the above
symptoms.

Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or that does not go away.


REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN
INFECTION, INCLUDING:

 * Fever, sweats, or chills
 * Muscle aches
 * Cough
 * Shortness of breath
 * Blood in phlegm
 * Weight loss
 * Warm, red, or painful skin or sores on your body
 * Diarrhea or stomach pain
 * Burning when you urinate
 * Urinating more often than normal
 * Feeling very tired

HUMIRA is given by injection under the skin.

This is the most important information to know about HUMIRA. For more
information, talk to your health care provider.

Uses

HUMIRA is a prescription medicine used:

 * To reduce the signs and symptoms of:
   * Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used
     alone, with methotrexate, or with certain other medicines. HUMIRA may
     prevent further damage to your bones and joints and may help your ability
     to perform daily activities.
   * Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in
     children 2 years of age and older. HUMIRA can be used alone or with
     methotrexate.
   * Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with
     certain other medicines. HUMIRA may prevent further damage to your bones
     and joints and may help your ability to perform daily activities.
   * Ankylosing spondylitis (AS) in adults.
   * Moderate to severe hidradenitis suppurativa (HS) in people 12 years and
     older.
 * To treat moderate to severe Crohn’s disease (CD) in adults and children 6
   years of age and older.
 * To treat moderate to severe ulcerative colitis (UC) in adults and children 5
   years of age and older. It is not known if HUMIRA is effective in people who
   stopped responding to or could not tolerate anti-TNF medicines.
 * To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are
   ready for systemic therapy or phototherapy, and are under the care of a
   doctor who will decide if other systemic therapies are less appropriate.
 * To treat non-infectious intermediate (middle part of the eye), posterior
   (back of the eye), and panuveitis (all parts of the eye) in adults and
   children 2 years of age and older.

US-HUM-210186

Please see the Full Prescribing Information, including the Medication Guide, for
HUMIRA.

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to
help. Visit AbbVie.com/myAbbVieAssist to learn more.

Legal Notices/Privacy Policy. Copyright 2013, AbbVie Inc., North Chicago,
Illinois, U.S.A. If you have any questions about AbbVie’s HUMIRA.com website
that have not been answered click here. This website and the information
contained herein is intended for use by US residents only, is provided for
informational purposes only and is not intended to replace a discussion with a
healthcare provider. All decisions regarding patient care must be made with a
healthcare provider and consider the unique characteristics of each patient.

Reference: 1. HUMIRA Injection [package insert]. North Chicago, IL: AbbVie Inc.

CONDITIONS HUMIRA TREATS

 * Moderate to Severe Rheumatoid Arthritis
 * Moderate to Severe Chronic Plaque Psoriasis
 * Moderate to Severe Crohn's Disease
 * Moderate to Severe Pediatric Crohn's Disease
 * Moderate to Severe Ulcerative Colitis
 * Moderate to Severe Pediatric Ulcerative Colitis
 * Psoriatic Arthritis
 * Moderate to Severe Hidradenitis Suppurativa
 * Ankylosing Spondylitis
 * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
 * Non-Infectious Intermediate, Posterior, and Panuveitis
 * About HUMIRA Complete
 * Complete Resource Center
 * Cost & Savings
 * Chat 24/7 on the HUMIRA Complete Answers Facebook Page

IMPORTANT SAFETY INFORMATION FOR PATIENTS

 * Important Safety Information
 * Medication Guide
 * Full Prescribing Information
 * Información en Español

INFORMATION FROM ABBVIE

 * Contact Us
 * Privacy Policy
 * Terms of Use
 * Advertising Choices
 * Cookies Settings
 * Health Care Professional Site

--------------------------------------------------------------------------------

 © 2013 AbbVie Inc.

US-HUM-220482






ABBVIE MEDICATION REMINDER'S TERMS AND CONDITIONS

By checking the box, I authorize AbbVie and its third party contractors to send
me autodialed text message medication reminders to the mobile phone number that
I provided. I understand that I am not required to sign this consent, and that
signing this consent is not a condition for me to purchase any product or
services from AbbVie. I understand that standard message and data rates may
apply.

I understand I can opt-out of receiving AbbVie medication reminders at any time
by texting STOP to 80153, or by contacting AbbVie Customer Service. If I need
additional information on AbbVie Medication Reminder program, I can text HELP to
80153, or call 1-800-448-6472.

Message frequency depends on the user. There is no charge to participate in the
AbbVie Medication Reminder program; however, message and data rates may apply
(please contact your mobile carrier for further details on message and data
rates under your mobile plan).

AbbVie Medication Reminders service available on these US carriers only: Verizon
Wireless, Sprint, Nextel , Boost, T-Mobile®, AT&T, Alltel, ACS Wireless,
Bluegrass Cellular, Carolina West Wireless, CellCom, Cellular One of East
Central Illinois (ECIT), Cincinnati Bell, Cricket, C-Spire Wireless, Duet IP
(AKA Max/Benton/Albandy), Element Mobile, Epic Touch, GCI Communications, Golden
State, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Valley
Cellular (IVC), Inland Cellular, iWireless, Keystone Wireless (Immix/PC
Management), MetroPCS, MobiPCS, Mosaic, MTPCS/Cellular One (Cellone Nation),
Nex-Tech Wireless, nTelos, Panhandle Telecommunications, Pioneer, Plateau, Revol
Wireless, Rina-Custer, Rina-All West, Rina- Cambridge Telecom Coop, RinaEagle
Valley Comm, Rina-Farmers Mutual Telephone Co, Rina-Nucla Nutria Telephone Co,
Rina- Silver Star, Rina- South Central Comm, Rina- Syringa, Rina- UBET, Rina-
Manti, Simmetry, South Canaan/CellularOne of NEPA, Thumb Cellular, Union
Wireless, United Wireless, U.S. Cellular, Viaero Wireless, Virgin Mobile, West
Central Wireless (includes Five Star Wireless). Please consult the application
wireless service agreement for your individual pricing plan.

Alerts sent via SMS may not be delivered to you if your phone is not in range of
a transmission site, or if sufficient network capacity is not available at a
particular time. Even within a coverage area, factors beyond the control of your
wireless carrier may interfere with message delivery, including the customer's
equipment, terrain, proximity to buildings, foliage, and weather. You
acknowledge that urgent alerts may not be timely received and that your wireless
carrier does not guarantee that alerts will be delivered.

US-HUM-220482

HUMIRA_Complete_Patient_Stories


Video Player is loading.
Play Video
Play
Mute

Current Time 0:00
/
Duration 2:51
Loaded: 5.78%


0:00

Stream Type LIVE
Seek to live, currently behind liveLIVE
Remaining Time -2:51
 
1x
Playback Rate
 * 2x
 * 1.75x
 * 1.5x
 * 1.25x
 * 1x, selected
 * 0.75x
 * 0.5x

Chapters
 * Chapters

Descriptions
 * descriptions off, selected

Captions
 * captions settings, opens captions settings dialog
 * captions off, selected

Audio Track
 * en (Main), selected

Quality Levels

Picture-in-PictureFullscreen

This is a modal window.



Beginning of dialog window. Escape will cancel and close the window.

TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque
Font Size50%75%100%125%150%175%200%300%400%Text Edge
StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional
Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall
Caps
Reset restore all settings to the default valuesDone
Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or
activating the close button.





HUMIRA_COMPLETE_PATIENT_STORIES



Transcript


PAINTING A PICTURE OF HUMIRA COMPLETE

View Transcript

It’s one thing to talk about dedicated, one-to-one service. It’s quite another
to experience it for yourself. Here, 3 people tell their unique personal stories
about starting and staying on track with their HUMIRA treatment —and the ways
that HUMIRA Complete has helped them access what they’ve needed, when they’ve
needed it.

What will you discover with HUMIRA Complete?


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUM-210439


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUM-210439

From doorbell to disposal.
This quick video will show you how to use your new sharps container, to dispose
of your used sharps and how to send it back – at no additional cost to you –
when it’s almost full.

Video Player is loading.
Play Video
Play
Mute

Current Time 0:00
/
Duration 2:56
Loaded: 5.56%


0:00

Stream Type LIVE
Seek to live, currently behind liveLIVE
Remaining Time -2:56
 
1x
Playback Rate
 * 2x
 * 1.75x
 * 1.5x
 * 1.25x
 * 1x, selected
 * 0.75x
 * 0.5x

Chapters
 * Chapters

Descriptions
 * descriptions off, selected

Captions
 * captions settings, opens captions settings dialog
 * captions off, selected

Audio Track
 * en (Main), selected

Quality Levels
 * 720p720pHD
 * 576p576p
 * 360p3, selected
 * 216p216p
 * AutoAuto

Picture-in-PictureFullscreen

This is a modal window.



Beginning of dialog window. Escape will cancel and close the window.

TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque
Font Size50%75%100%125%150%175%200%300%400%Text Edge
StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional
Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall
Caps
Reset restore all settings to the default valuesDone
Close Modal Dialog

End of dialog window.

Close Modal Dialog

This is a modal window. This modal can be closed by pressing the Escape key or
activating the close button.





FROM DOORBELL TO DISPOSAL.

This quick video will show you how to use your new sharps container, to dispose
of your used sharps and how to send it back – at no additional cost to you –
when it’s almost full.

Transcript


YOUR SHARPS CONTAINER AND MAIL-BACK DISPOSAL KIT

This quick video will show you how to use your new sharps container, to dispose
of your used sharps and how to send it back – at no additional cost to you- when
it’s almost full.


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUM-220495


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience, and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy, for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUM-220495


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUM-220495

CHOOSE YOUR CONDITION

Moderate to Severe
Rheumatoid Arthritis
Moderate to Severe Chronic
Plaque Psoriasis
Moderate to Severe
Crohn's Disease
Moderate to Severe
Pediatric Crohn's Disease
Moderate to Severe
Ulcerative Colitis
Moderate to Severe
Pediatric Ulcerative Colitis
Psoriatic Arthritis
Moderate to Severe
Hidradenitis Suppurativa
Ankylosing Spondylitis
Moderate to Severe Polyarticular
Juvenile Idiopathic Arthritis
Intermediate, Posterior, and Panuveitis
Non-Infectious Uveitis


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUM-220495


LEAVING ABBVIE WEB SITE

You are leaving the AbbVie Web site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of HUMIRA.com or AbbVie.

Do you wish to leave this site?

Yes
No

US-HUMG-230019




IMPORTANT SAFETY INFORMATION1

You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections. Your doctor should test you for TB before
starting HUMIRA, and check you closely for signs and symptoms of TB during
treatment with HUMIRA, even if your TB test was negative. If your doctor feels
you are at risk, you may be treated with medicine for TB.


IMPORTANT SAFETY INFORMATION1

You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include


IMPORTANT SAFETY INFORMATION1

You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections. Your doctor should test you for TB before
starting HUMIRA, and check you closely for signs and symptoms of TB during
treatment with HUMIRA, even if your TB test was negative. If your doctor feels
you are at risk, you may be treated with medicine for TB.

Cancer. For children and adults taking TNF blockers, including HUMIRA, the
chance of getting lymphoma or other cancers may increase. There have been cases
of

unusual


IMPORTANT SAFETY INFORMATION1

You should not start taking HUMIRA if you have any kind of infection unless your
doctor says it is okay. Serious infections have happened in people taking
HUMIRA. These serious infections include tuberculosis (TB) and infections caused
by viruses, fungi, or bacteria that have spread throughout the body. Some people
have died from these infections.


IMPORTANT SAFETY INFORMATION 
ABOUT HUMIRA® (ADALIMUMAB)1


WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD KNOW ABOUT HUMIRA?

You should discuss the potential benefits and risks of HUMIRA with your doctor.
HUMIRA is a TNF blocker medicine that can lower the ability of your immune
system to fight infections. You should not start taking HUMIRA if you have any
kind of infection unless your doctor says it is okay.

 * Serious infections have happened in people taking HUMIRA. These serious
   infections include tuberculosis (TB) and infections caused by viruses, fungi,
   or bacteria that have spread throughout the body. Some people have died from
   these infections. Your doctor should test you for TB before starting HUMIRA,
   and check you closely for signs and symptoms of TB during treatment with
   HUMIRA, even if your TB test was negative. If your doctor feels you are at
   risk, you may be treated with medicine for TB.
 * Cancer. For children and adults taking TNF blockers, including HUMIRA, the
   chance of getting lymphoma or other cancers may increase. There have been
   cases of unusual cancers in children, teenagers, and young adults using TNF
   blockers. Some people have developed a rare type of cancer called
   hepatosplenic T-cell lymphoma. This type of cancer often results in death. If
   using TNF blockers including HUMIRA, your chance of getting two types of skin
   cancer (basal cell and squamous cell) may increase. These types are generally
   not life-threatening if treated; tell your doctor if you have a bump or open
   sore that doesn’t heal.


WHAT SHOULD I TELL MY DOCTOR BEFORE STARTING HUMIRA?

Tell your doctor about all of your health conditions, including if you:

 * Have an infection, are being treated for infection, or have symptoms of an
   infection
 * Get a lot of infections or infections that keep coming back
 * Have diabetes
 * Have TB or have been in close contact with someone with TB, or were born in,
   lived in, or traveled where there is more risk for getting TB
 * Live or have lived in an area (such as the Ohio and Mississippi River
   valleys) where there is an increased risk for getting certain kinds of fungal
   infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis.
   These infections may happen or become more severe if you use HUMIRA. Ask your
   doctor if you are unsure if you have lived in these areas
 * Have or have had hepatitis B
 * Are scheduled for major surgery
 * Have or have had cancer
 * Have numbness or tingling or a nervous system disease such as multiple
   sclerosis or Guillain-Barré syndrome
 * Have or had heart failure
 * Have recently received or are scheduled to receive a vaccine. HUMIRA patients
   may receive vaccines, except for live vaccines. Children should be brought up
   to date on all vaccines before starting HUMIRA
 * Are allergic to rubber, latex, or any HUMIRA ingredients
 * Are pregnant, planning to become pregnant, breastfeeding, or planning to
   breastfeed
 * Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s
   doctor before your baby receives any vaccines

Also tell your doctor about all the medicines you take. You should not take
HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab),
ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab).
Tell your doctor if you have ever used RITUXAN® (rituximab),
IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).


WHAT SHOULD I WATCH FOR AFTER STARTING HUMIRA?

HUMIRA can cause serious side effects, including:

 * Serious infections. These include TB and infections caused by viruses, fungi,
   or bacteria. Symptoms related to TB include a cough, low-grade fever, weight
   loss, or loss of body fat and muscle.
 * Hepatitis B infection in carriers of the virus. Symptoms include muscle
   aches, feeling very tired, dark urine, skin or eyes that look yellow, little
   or no appetite, vomiting, clay-colored bowel movements, fever, chills,
   stomach discomfort, and skin rash.
 * Allergic reactions. Symptoms of a serious allergic reaction include hives,
   trouble breathing, and swelling of your face, eyes, lips, or mouth.
 * Nervous system problems. Signs and symptoms include numbness or tingling,
   problems with your vision, weakness in your arms or legs, and dizziness.
 * Blood problems (decreased blood cells that help fight infections or stop
   bleeding). Symptoms include a fever that does not go away, bruising or
   bleeding very easily, or looking very pale.
 * Heart failure (new or worsening). Symptoms include shortness of breath,
   swelling of your ankles or feet, and sudden weight gain.
 * Immune reactions including a lupus-like syndrome. Symptoms include chest
   discomfort or pain that does not go away, shortness of breath, joint pain, or
   rash on your cheeks or arms that gets worse in the sun.
 * Liver problems. Symptoms include feeling very tired, skin or eyes that look
   yellow, poor appetite or vomiting, and pain on the right side of your stomach
   (abdomen). These problems can lead to liver failure and death.
 * Psoriasis (new or worsening). Symptoms include red scaly patches or raised
   bumps that are filled with pus.

Call your doctor or get medical care right away if you develop any of the above
symptoms.

Common side effects of HUMIRA include injection site reactions (pain, redness,
rash, swelling, itching, or bruising), upper respiratory infections (sinus
infections), headaches, rash, and nausea. These are not all of the possible side
effects with HUMIRA. Tell your doctor if you have any side effect that bothers
you or that does not go away.


REMEMBER, TELL YOUR DOCTOR RIGHT AWAY IF YOU HAVE AN INFECTION OR SYMPTOMS OF AN
INFECTION, INCLUDING:

 * Fever, sweats, or chills
 * Muscle aches
 * Cough
 * Shortness of breath
 * Blood in phlegm
 * Weight loss
 * Warm, red, or painful skin or sores on your body
 * Diarrhea or stomach pain
 * Burning when you urinate
 * Urinating more often than normal
 * Feeling very tired

HUMIRA is given by injection under the skin.

This is the most important information to know about HUMIRA. For more
information, talk to your health care provider.

Uses

HUMIRA is a prescription medicine used:

 * To reduce the signs and symptoms of:
   * Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used
     alone, with methotrexate, or with certain other medicines. HUMIRA may
     prevent further damage to your bones and joints and may help your ability
     to perform daily activities.
   * Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in
     children 2 years of age and older. HUMIRA can be used alone or with
     methotrexate.
   * Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with
     certain other medicines. HUMIRA may prevent further damage to your bones
     and joints and may help your ability to perform daily activities.
   * Ankylosing spondylitis (AS) in adults.
   * Moderate to severe hidradenitis suppurativa (HS) in people 12 years and
     older.
 * To treat moderate to severe Crohn’s disease (CD) in adults and children 6
   years of age and older.
 * To treat moderate to severe ulcerative colitis (UC) in adults and children 5
   years of age and older. It is not known if HUMIRA is effective in people who
   stopped responding to or could not tolerate anti-TNF medicines.
 * To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are
   ready for systemic therapy or phototherapy, and are under the care of a
   doctor who will decide if other systemic therapies are less appropriate.
 * To treat non-infectious intermediate (middle part of the eye), posterior
   (back of the eye), and panuveitis (all parts of the eye) in adults and
   children 2 years of age and older.

US-HUM-210186

This site uses online tracking technologies such as cookies to personalize
content, save your preferences, provide social media features, enable
personalized advertising and track the site’s performance as described in our
Privacy Notice. Please click on Cookies Settings below to manage your
preferences.


Cookies Settings



PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience.

You can choose not to allow some types of cookies. Click on the different
category headings to find out more and change our default settings. However,
blocking some types of cookies may impact your experience of the site and the
services we are able to offer.
More information


MANAGE CONSENT PREFERENCES

REQUIRED COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They may be set by us or by third party providers whose
services we have added to our pages. They are usually only set in response to
actions made by you which amount to a request for services, such as setting your
privacy preferences, logging in or filling in forms. You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work.

FUNCTIONAL COOKIES

Always Active

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.

ADVERTISING COOKIES

Advertising Cookies

These cookies may be set through our site by our advertising partners to build a
profile of your interests and show you relevant adverts on other sites. They do
not store directly personal information but are based on uniquely identifying
your browser and internet device. If you do not allow these cookies, you will
experience less targeted advertising, but you will still receive online
advertising.

Back Button


PERFORMANCE COOKIES



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices


Live chat:Chat Live 24/7